Research Summary
Biosimilar insulin is a type of insulin that is similar in structure and function to the original insulin product. Biosimilar insulins are designed to work in the same way as the branded insulin products but are produced by different manufacturers. Biosimilar insulin products have undergone extensive testing to prove that they are just as safe, effective, and reliable as the original insulin products. Biosimilar insulin is typically less expensive than the branded insulin products, which may make it more accessible for individuals who need insulin treatment.
According to DIResearch's in-depth investigation and research, the global Biosimilar Insulin market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Biosimilar Insulin include Eli Lilly, Sanofi, Gan&Lee, Tonghua Dongbao, United Laboratory, Geropharm, Biocon, Wockhardt etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Biosimilar Insulin. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Biosimilar Insulin market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Biosimilar Insulin market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Biosimilar Insulin industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Biosimilar Insulin Include:
Eli Lilly
Sanofi
Gan&Lee
Tonghua Dongbao
United Laboratory
Geropharm
Biocon
Wockhardt
Biosimilar Insulin Product Segment Include:
Biosimilar Insulin Glargine
Biosimilar Insulin Lispro
Other
Biosimilar Insulin Product Application Include:
Hospital
Retail Pharmacy
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Biosimilar Insulin Industry PESTEL Analysis
Chapter 3: Global Biosimilar Insulin Industry Porter's Five Forces Analysis
Chapter 4: Global Biosimilar Insulin Major Regional Market Size and Forecast Analysis
Chapter 5: Global Biosimilar Insulin Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Biosimilar Insulin Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Biosimilar Insulin Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Biosimilar Insulin Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Biosimilar Insulin Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Biosimilar Insulin Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Biosimilar Insulin Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Biosimilar Insulin Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Biosimilar Insulin Market Overview 1.1 Product Definition and Statistical Scope 1.2 Biosimilar Insulin Product by Type 1.2.1 Global Biosimilar Insulin Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 Biosimilar Insulin Glargine 1.2.3 Biosimilar Insulin Lispro 1.2.4 Other 1.3 Biosimilar Insulin Product by Application 1.3.1 Global Biosimilar Insulin Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Hospital 1.3.3 Retail Pharmacy 1.3.4 Others 1.4 Global Biosimilar Insulin Market Revenue Analysis (2019-2030) 1.5 Biosimilar Insulin Market Development Status and Trends 1.5.1 Biosimilar Insulin Industry Development Status Analysis 1.5.2 Biosimilar Insulin Industry Development Trends Analysis 2 Biosimilar Insulin Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Biosimilar Insulin Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Biosimilar Insulin Market Analysis by Regions 4.1 Biosimilar Insulin Overall Market: 2023 VS 2024 VS 2030 4.2 Global Biosimilar Insulin Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Biosimilar Insulin Revenue and Market Share by Region (2019-2024) 4.2.2 Global Biosimilar Insulin Revenue Forecast by Region (2025-2030) 5 Global Biosimilar Insulin Market Size by Type and Application 5.1 Global Biosimilar Insulin Market Size by Type 5.2 Global Biosimilar Insulin Market Size by Application 6 North America 6.1 North America Biosimilar Insulin Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Biosimilar Insulin Market Size by Type 6.4 North America Biosimilar Insulin Market Size by Application 6.5 North America Biosimilar Insulin Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Biosimilar Insulin Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Biosimilar Insulin Market Size by Type 7.4 Europe Biosimilar Insulin Market Size by Application 7.5 Europe Biosimilar Insulin Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Biosimilar Insulin Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Biosimilar Insulin Market Size by Type 8.4 China Biosimilar Insulin Market Size by Application 9 APAC (excl. China) 9.1 APAC (excl. China) Biosimilar Insulin Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Biosimilar Insulin Market Size by Type 9.4 APAC (excl. China) Biosimilar Insulin Market Size by Application 9.5 APAC (excl. China) Biosimilar Insulin Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Biosimilar Insulin Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Biosimilar Insulin Market Size by Type 10.4 Latin America Biosimilar Insulin Market Size by Application 10.5 Latin America Biosimilar Insulin Market Size by Country 10.5.1 Mecixo 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Biosimilar Insulin Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Biosimilar Insulin Market Size by Type 11.4 Middle East & Africa Biosimilar Insulin Market Size by Application 11.5 Middle East & Africa Biosimilar Insulin Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Market Competition by Manufacturers 12.1 Global Biosimilar Insulin Market Revenue by Key Manufacturers (2020-2024) 12.2 Biosimilar Insulin Competitive Landscape Analysis and Market Dynamic 12.2.1 Biosimilar Insulin Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Eli Lilly 13.1.1 Eli Lilly Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Eli Lilly Biosimilar Insulin Product Portfolio 13.1.3 Eli Lilly Biosimilar Insulin Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.2 Sanofi 13.2.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 Sanofi Biosimilar Insulin Product Portfolio 13.2.3 Sanofi Biosimilar Insulin Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.3 Gan&Lee 13.3.1 Gan&Lee Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 Gan&Lee Biosimilar Insulin Product Portfolio 13.3.3 Gan&Lee Biosimilar Insulin Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.4 Tonghua Dongbao 13.4.1 Tonghua Dongbao Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 Tonghua Dongbao Biosimilar Insulin Product Portfolio 13.4.3 Tonghua Dongbao Biosimilar Insulin Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.5 United Laboratory 13.5.1 United Laboratory Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 United Laboratory Biosimilar Insulin Product Portfolio 13.5.3 United Laboratory Biosimilar Insulin Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.6 Geropharm 13.6.1 Geropharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 Geropharm Biosimilar Insulin Product Portfolio 13.6.3 Geropharm Biosimilar Insulin Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.7 Biocon 13.7.1 Biocon Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 Biocon Biosimilar Insulin Product Portfolio 13.7.3 Biocon Biosimilar Insulin Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.8 Wockhardt 13.8.1 Wockhardt Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 Wockhardt Biosimilar Insulin Product Portfolio 13.8.3 Wockhardt Biosimilar Insulin Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Biosimilar Insulin Industry Chain Analysis 14.2 Biosimilar Insulin Industry Raw Material and Suppliers Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Biosimilar Insulin Typical Downstream Customers 14.4 Biosimilar Insulin Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support